Manufacturer submission guide finalized
The Health Care Authority (HCA) is writing you with more critical information pertaining to the Prescription Drug Price Transparency program.
Please read carefully and save for your records.
HCA has finalized the manufacturer submission guide
The 30-day review period for the last published guide has passed, and HCA has finalized the manufacturer submission guide effective 1/7/2021. Please download the new version on our website as it replaces all prior versions.
Questions?
Please stay connected with us via our drug price transparency webpage. Here you can receive updates and contact us via email.
|